Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft-vs.-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04302506
What this trial is testing

Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury

Who this might be right for
Drug-induced Liver Injury
Beijing Ditan Hospital 600
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT03805477
What this trial is testing

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland 20
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07354074
What this trial is testing

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals 50
Not applicableEnded earlyNCT02458859
What this trial is testing

Trial of PICO Versus Standard Care in Chronic and Sub-acute Wounds

Who this might be right for
Wounds
Smith & Nephew, Inc. 62
Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Not applicableLooking for participantsNCT06939660
What this trial is testing

BCI-Assisted SCS-EXS for Gait Optimization

Who this might be right for
Spinal Cord Injuries (SCI)Spinal Cord Injury, ChronicSpinal Cord Injury+7 more
Xuanwu Hospital, Beijing 3
Early research (Phase 1)Looking for participantsNCT06233110
What this trial is testing

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Who this might be right for
Chronic Graft Versus Host Disease
Stefanie Sarantopoulos, MD, PhD. 30
Testing effectiveness (Phase 2)Ended earlyNCT04446182
What this trial is testing

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Who this might be right for
Chronic Graft-versus-host-disease
University of Utah 3
Early research (Phase 1)Study completedNCT04987333
What this trial is testing

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Who this might be right for
Inflammatory Diseases
Amgen 32
Not applicableLooking for participantsNCT06873308
What this trial is testing

Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis

Who this might be right for
Schistosomiasis
IRCCS Sacro Cuore Don Calabria di Negrar 278
Not applicableAvailableNCT07210619
What this trial is testing

Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Who this might be right for
oGVHD
Regenerative Ocular Immunobiologics LLC
Not applicableNot Yet RecruitingNCT07189741
What this trial is testing

Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy

Who this might be right for
UremiaUremia; ChronicHemodialysis
Second People's Hospital, Shanghai 50
Not applicableUnknownNCT03458286
What this trial is testing

A Study Measuring the Effectiveness of Combined Modulated Ultrasound and Electric Current Stimulation as an Adjunctive Treatment in Treating Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Royal College of Surgeons, Ireland 50
Large-scale testing (Phase 3)Ended earlyNCT01901302
What this trial is testing

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Who this might be right for
Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 61
Not applicableStudy completedNCT05578781
What this trial is testing

Music-based Treatments and Pain: Underlying Mechanisms and the Beneficial Effects of Music-Based Treatments

Who this might be right for
Chronic Low-back Pain
University of Washington 99
Testing effectiveness (Phase 2)Study completedNCT00822770
What this trial is testing

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 47
Not applicableStudy completedNCT01174277
What this trial is testing

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

Who this might be right for
Blood Stem Cell Transplant FailureGraft Versus Host Disease
University of Kansas Medical Center 23
Next Page